The Oncologist: Best Practices in Chronic Myeloid Leukemia Monitoring and Management

Learning Objectives: 1. Discuss the definition of key MR milestones by BCR-ABL1 transcript levels and the clinical meaning of each milestone. 2. Discuss the correct timing of MR assessment, how are MR results generated, and which variables may influence and in some cases compromise the reliability and clinical value of such results. 3. Incorporate MR and BCR-ABL1 mutation results into clinical decision algorithms. Optimal use of current therapeutic opportunities for chronic myeloid leuke...
Society For Translational Oncology

Expert Update: What's New in Essential Thrombocythemia

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient quality of life. Recent revisions in the classification of myeloid neoplasms and acute leukemia by the World Health Organization have further defined criteria for the differential diagnosis of MPNs, including criteria for the discernment of essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis. However, many ch...
Slack Inc.

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.